172 related articles for article (PubMed ID: 30038238)
41. Vancomycin induces reactive oxygen species-dependent apoptosis via mitochondrial cardiolipin peroxidation in renal tubular epithelial cells.
Sakamoto Y; Yano T; Hanada Y; Takeshita A; Inagaki F; Masuda S; Matsunaga N; Koyanagi S; Ohdo S
Eur J Pharmacol; 2017 Apr; 800():48-56. PubMed ID: 28216050
[TBL] [Abstract][Full Text] [Related]
42. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia.
Edgar JM; McLaughlin M; Yool D; Zhang SC; Fowler JH; Montague P; Barrie JA; McCulloch MC; Duncan ID; Garbern J; Nave KA; Griffiths IR
J Cell Biol; 2004 Jul; 166(1):121-31. PubMed ID: 15226307
[TBL] [Abstract][Full Text] [Related]
43. Beneficial effects of rapamycin in a Drosophila model for hereditary spastic paraplegia.
Xu S; Stern M; McNew JA
J Cell Sci; 2017 Jan; 130(2):453-465. PubMed ID: 27909242
[TBL] [Abstract][Full Text] [Related]
44. Autopsy case of autosomal recessive hereditary spastic paraplegia with reference to the muscular pathology.
Nomura H; Koike F; Tsuruta Y; Iwaki A; Iwaki T
Neuropathology; 2001 Sep; 21(3):212-7. PubMed ID: 11666018
[TBL] [Abstract][Full Text] [Related]
45. A lysophospholipid acyltransferase antagonist, CI-976, creates novel membrane tubules marked by intracellular phospholipase A1 KIAA0725p.
Baba T; Yamamoto A; Tagaya M; Tani K
Mol Cell Biochem; 2013 Apr; 376(1-2):151-61. PubMed ID: 23378048
[TBL] [Abstract][Full Text] [Related]
46. Advances in hereditary spastic paraplegia.
Fink JK
Curr Opin Neurol; 1997 Aug; 10(4):313-8. PubMed ID: 9266155
[TBL] [Abstract][Full Text] [Related]
47. Hereditary spastic paraplegia: identification of an SPG3A gene mutation in a Chinese family.
Chan KY; Ching CK; Mak CM; Lam CW; Chan AY
Hong Kong Med J; 2009 Aug; 15(4):304-7. PubMed ID: 19652243
[TBL] [Abstract][Full Text] [Related]
48. A novel mutation in PLP1 causes severe hereditary spastic paraplegia type 2.
Noetzli L; Sanz PG; Brodsky GL; Hinckley JD; Giugni JC; Giannaula RJ; Gonzalez-Alegre P; Di Paola J
Gene; 2014 Jan; 533(1):447-50. PubMed ID: 24103481
[TBL] [Abstract][Full Text] [Related]
49. Translating m-AAA protease function in mitochondria to hereditary spastic paraplegia.
Rugarli EI; Langer T
Trends Mol Med; 2006 Jun; 12(6):262-9. PubMed ID: 16647881
[TBL] [Abstract][Full Text] [Related]
50. The "broken wishbone" splenial sign: A diagnostic hallmark for SPG54 spastic ataxia.
Zaidi SA; Saal HM; Espay AJ; Duker AP
J Neurol Sci; 2019 Aug; 403():114-116. PubMed ID: 31271950
[No Abstract] [Full Text] [Related]
51. Hereditary spastic paraplegias.
Lau KK; Ching CK; Mak CM; Chan YW
Hong Kong Med J; 2009 Jun; 15(3):217-20. PubMed ID: 19494379
[TBL] [Abstract][Full Text] [Related]
52. Impairment of brain and muscle energy metabolism detected by magnetic resonance spectroscopy in hereditary spastic paraparesis type 28 patients with DDHD1 mutations.
Liguori R; Giannoccaro MP; Arnoldi A; Citterio A; Tonon C; Lodi R; Bresolin N; Bassi MT
J Neurol; 2014 Sep; 261(9):1789-93. PubMed ID: 24989667
[TBL] [Abstract][Full Text] [Related]
53. Spinal cord magnetic resonance imaging in autosomal dominant hereditary spastic paraplegia.
Hedera P; Eldevik OP; Maly P; Rainier S; Fink JK
Neuroradiology; 2005 Oct; 47(10):730-4. PubMed ID: 16143870
[TBL] [Abstract][Full Text] [Related]
54. Molecular aspects of hereditary spastic paraplegia.
Noreau A; Dion PA; Rouleau GA
Exp Cell Res; 2014 Jul; 325(1):18-26. PubMed ID: 24631291
[TBL] [Abstract][Full Text] [Related]
55. Exome sequencing reveals novel SPG11 mutation in hereditary spastic paraplegia with complicated phenotypes.
Li YS; Mao CY; Shi CH; Song B; Wu J; Qin J; Ji Y; Niu HX; Luo HY; Shang DD; Sun SL; Xu YM
J Clin Neurosci; 2015 Jul; 22(7):1150-4. PubMed ID: 26003865
[TBL] [Abstract][Full Text] [Related]
56. Loss of cardiolipin and mitochondria during programmed neuronal death: evidence of a role for lipid peroxidation and autophagy.
Kirkland RA; Adibhatla RM; Hatcher JF; Franklin JL
Neuroscience; 2002; 115(2):587-602. PubMed ID: 12421624
[TBL] [Abstract][Full Text] [Related]
57. Novel De Novo Mutations in KIF1A as a Cause of Hereditary Spastic Paraplegia With Progressive Central Nervous System Involvement.
Hotchkiss L; Donkervoort S; Leach ME; Mohassel P; Bharucha-Goebel DX; Bradley N; Nguyen D; Hu Y; Gurgel-Giannetti J; Bönnemann CG
J Child Neurol; 2016 Aug; 31(9):1114-9. PubMed ID: 27034427
[TBL] [Abstract][Full Text] [Related]
58. Novel Genetic, Clinical, and Pathomechanistic Insights into TFG-Associated Hereditary Spastic Paraplegia.
Harlalka GV; McEntagart ME; Gupta N; Skrzypiec AE; Mucha MW; Chioza BA; Simpson MA; Sreekantan-Nair A; Pereira A; Günther S; Jahic A; Modarres H; Moore-Barton H; Trembath RC; Kabra M; Baple EL; Thakur S; Patton MA; Beetz C; Pawlak R; Crosby AH
Hum Mutat; 2016 Nov; 37(11):1157-1161. PubMed ID: 27492651
[TBL] [Abstract][Full Text] [Related]
59. [Construction of wild-type and mutant SPAST vectors for the study of molecular mechanism of hereditary spastic paraplegia].
Yan YP; Pu JL; Zhang BR; Zhao GH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):9-12. PubMed ID: 23450470
[TBL] [Abstract][Full Text] [Related]
60. A founder mutation p.H701P identified as a major cause of SPG7 in Norway.
Rydning SL; Wedding IM; Koht J; Chawla M; Øye AM; Sheng Y; Vigeland MD; Selmer KK; Tallaksen CM
Eur J Neurol; 2016 Apr; 23(4):763-71. PubMed ID: 26756429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
